* Zimmer Biomet reports certain preliminary second quarter 2017 results

* Zimmer Biomet Holdings Inc says Q2 adjusted earnings per share to be at or near bottom of its previous guidance range of $2.08 to $2.13

* Zimmer Biomet - expected Q2 constant currency revenue decrease is below Co's previous guidance of growth of 0.0% to 1.0% on similar basis

* Sees Q2 revenue about $1.954 billion

* Sees Q2 revenue up 1.1 percent

* Zimmer Biomet Holdings Inc - estimates that foreign exchange rates had a favorable impact of 120 basis points relative to what was assumed in Q2 guidance

* Zimmer Biomet Holdings Inc - had previously anticipated Q2 revenues in range of $1.940 billion to $1.960 billion

* Q2 revenue view $1.95 billion -- Thomson Reuters I/B/E/S

* Zimmer Biomet Holdings - excluding items, Q2 2017 revenues are expected to decrease by 1.3% from Q2 of 2016

* Unable to provide estimated GAAP diluted earnings per share results for Q2 2017 Source text for Eikon: Further company coverage: